{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:35:46Z","timestamp":1791005746860,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:00:00Z","timestamp":1748390400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Young and Middle-aged Talent Cultivation Projects of Fujian Province","award":["2024GGB27"],"award-info":[{"award-number":["2024GGB27"]}]},{"name":"Young and Middle-aged Talent Cultivation Projects of Xiamen city","award":["2024GZL-GG10"],"award-info":[{"award-number":["2024GZL-GG10"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304629"],"award-info":[{"award-number":["82304629"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2024J08304"],"award-info":[{"award-number":["2024J08304"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016808","name":"Natural Science Foundation of Xiamen Municipality","doi-asserted-by":"publisher","award":["3502Z202371048"],"award-info":[{"award-number":["3502Z202371048"]}],"id":[{"id":"10.13039\/100016808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s00415-025-13172-3","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T11:31:16Z","timestamp":1748431876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Safety concerns of maternal antiseizure medications exposure on perinatal and offspring outcomes: a disproportionality analysis based on FDA adverse event reporting system"],"prefix":"10.1007","volume":"272","author":[{"given":"Yanbin","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0625-8155","authenticated-orcid":false,"given":"Wanlong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1720-8882","authenticated-orcid":false,"given":"Wei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,28]]},"reference":[{"key":"13172_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S1474-4422(18)30495-2","volume":"18","author":"LJ Stephen","year":"2019","unstructured":"Stephen LJ, Harden C, Tomson T, Brodie MJ (2019) Management of epilepsy in women. Lancet Neurol 18:481\u2013491","journal-title":"Lancet Neurol"},{"key":"13172_CR2","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1212\/WNL.0000000000003647","volume":"88","author":"KJ Meador","year":"2017","unstructured":"Meador KJ, Lindhout D (2017) Epilepsy and unintended pregnancies. Neurology 88:724\u2013725","journal-title":"Neurology"},{"key":"13172_CR3","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/S0140-6736(15)00047-1","volume":"386","author":"KJ Meador","year":"2015","unstructured":"Meador KJ (2015) Risks during pregnancy in women with epilepsy. Lancet 386:1804\u20131805","journal-title":"Lancet"},{"key":"13172_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamaneurol.2024.0258","volume":"81","author":"D Battino","year":"2024","unstructured":"Battino D, Tomson T, Bonizzoni E et al (2024) Risk of major congenital malformations and exposure to antiseizure medication monotherapy. JAMA Neurol 81:481\u2013489","journal-title":"JAMA Neurol"},{"key":"13172_CR5","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","volume":"79","author":"M-H Bj\u00f8rk","year":"2022","unstructured":"Bj\u00f8rk M-H, Zoega H, Leinonen MK et al (2022) Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability. JAMA Neurol 79:672\u2013681","journal-title":"JAMA Neurol"},{"key":"13172_CR6","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1056\/NEJMoa0907328","volume":"362","author":"J Jentink","year":"2010","unstructured":"Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LTW, EUROCAT Antiepileptic Study Working Group (2010) Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 362:2185\u20132193","journal-title":"N Engl J Med"},{"key":"13172_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00002018-200629010-00001","volume":"29","author":"P Genton","year":"2006","unstructured":"Genton P, Semah F, Trinka E (2006) Valproic acid in epilepsy\u202f: pregnancy-related issues. Drug Saf 29:1\u201321","journal-title":"Drug Saf"},{"key":"13172_CR8","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/jnnp-2024-333620","volume":"95","author":"JW Dreier","year":"2024","unstructured":"Dreier JW, Christensen J (2024) Antiseizure medication and early pregnancy loss: should we be worried? J Neurol Neurosurg Psychiatry 95:691\u2013691","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13172_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/epi.18180","volume":"66","author":"P Perucca","year":"2025","unstructured":"Perucca P, Battino D, Bromley R et al (2025) Epilepsy-pregnancy registries: an update. Epilepsia 66:47\u201359","journal-title":"Epilepsia"},{"key":"13172_CR10","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1080\/14740338.2021.1943355","volume":"20","author":"CA Marxer","year":"2021","unstructured":"Marxer CA, R\u00fcegg S, Rauch MS, Panchaud A, Meier CR, Spoendlin J (2021) A review of the evidence on the risk of congenital malformations and neurodevelopmental disorders in association with antiseizure medications during pregnancy. Expert Opin Drug Saf 20:1487\u20131499","journal-title":"Expert Opin Drug Saf"},{"key":"13172_CR11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209279","volume":"102","author":"AM Pack","year":"2024","unstructured":"Pack AM, Oskoui M, Williams Roberson S et al (2024) Teratogenesis, perinatal, and neurodevelopmental outcomes after in utero exposure to antiseizure medication. Neurology 102:e209279","journal-title":"Neurology"},{"key":"13172_CR12","unstructured":"Epilepsy in Pregnancy (Green-top Guideline No. 68). In: RCOG. https:\/\/www.rcog.org.uk\/guidance\/browse-all-guidance\/green-top-guidelines\/epilepsy-in-pregnancy-green-top-guideline-no-68\/. Accessed 1 May 2025"},{"key":"13172_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0140-6736(24)01295-9","volume":"404","author":"EC Goligher","year":"2024","unstructured":"Goligher EC, Heath A, Harhay MO (2024) Bayesian statistics for clinical research. The Lancet 404:1067\u20131076","journal-title":"The Lancet"},{"key":"13172_CR14","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s11095-020-02801-3","volume":"37","author":"Y Noguchi","year":"2020","unstructured":"Noguchi Y, Tachi T, Teramachi H (2020) Comparison of signal detection algorithms based on frequency statistical model for drug-drug interaction using spontaneous reporting systems. Pharm Res 37:86","journal-title":"Pharm Res"},{"key":"13172_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30107-8","author":"T Tomson","year":"2018","unstructured":"Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F, Faravelli F, Pantaleoni C (2018) Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. https:\/\/doi.org\/10.1016\/S1474-4422(18)30107-8","journal-title":"Lancet Neurol"},{"key":"13172_CR16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","volume":"15","author":"AA Veroniki","year":"2017","unstructured":"Veroniki AA, Cogo E, Rios P et al (2017) Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med 15:95","journal-title":"BMC Med"},{"key":"13172_CR17","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/ana.26561","volume":"93","author":"JM Cohen","year":"2023","unstructured":"Cohen JM, Alvestad S, Cesta CE et al (2023) Comparative safety of antiseizure medication monotherapy for major malformations. Ann Neurol 93:551\u2013562","journal-title":"Ann Neurol"},{"key":"13172_CR18","volume":"2023","author":"R Bromley","year":"2023","unstructured":"Bromley R, Adab N, Bluett-Duncan M et al (2023) Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev 2023:CD010224","journal-title":"Cochrane Database Syst Rev"},{"key":"13172_CR19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s40272-018-0294-0","volume":"20","author":"G Koren","year":"2018","unstructured":"Koren G, Berkovitch M, Ornoy A (2018) Dose-dependent teratology in humans: clinical implications for prevention. Paediatr Drugs 20:331\u2013335","journal-title":"Paediatr Drugs"},{"key":"13172_CR20","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1212\/WNL.0b013e31827f0874","volume":"80","author":"E Mawhinney","year":"2013","unstructured":"Mawhinney E, Craig J, Morrow J et al (2013) Levetiracetam in pregnancy: results from the UK and Ireland epilepsy and pregnancy registers. Neurology 80:400\u2013405","journal-title":"Neurology"},{"key":"13172_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/epi.17800","volume":"65","author":"M Hoeltzenbein","year":"2024","unstructured":"Hoeltzenbein M, Bartz I, Fietz A-K, Lohse L, Onken M, Dathe K, Schaefer C (2024) Antiepileptic treatment with levetiracetam during the first trimester and pregnancy outcome: an observational study. Epilepsia 65:26\u201336","journal-title":"Epilepsia"},{"key":"13172_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.reprotox.2004.12.001","volume":"20","author":"K ten Berg","year":"2005","unstructured":"ten Berg K, Samr\u00e9n EB, van Oppen AC, Engelsman M, Lindhout D (2005) Levetiracetam use and pregnancy outcome. Reprod Toxicol 20:175\u2013178","journal-title":"Reprod Toxicol"},{"key":"13172_CR23","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1113\/jphysiol.2008.152298","volume":"586","author":"N Weiss","year":"2008","unstructured":"Weiss N, Ivanova E (2008) Does the voltage-gated calcium channel alpha2delta-1 subunit play a dual function in skeletal muscle? J Physiol 586:2035\u20132037","journal-title":"J Physiol"},{"key":"13172_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/bcp.15607","volume":"89","author":"JL Richardson","year":"2023","unstructured":"Richardson JL, Damkier P, Diav-Citrin O, George N, Greenall AJ, Oliver AM, Stephens S, Hodson KK (2023) A critical appraisal of controlled studies investigating malformation risks following pregabalin use in early pregnancy. Br J Clin Pharmacol 89:630\u2013640","journal-title":"Br J Clin Pharmacol"},{"key":"13172_CR25","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S0140-6736(75)90548-6","volume":"2","author":"MJ Safra","year":"1975","unstructured":"Safra MJ, Oakley GP (1975) Association between cleft lip with or without cleft palate and prenatal exposure to diazepam. Lancet 2:478\u2013480","journal-title":"Lancet"},{"key":"13172_CR26","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1056\/NEJM198311243092103","volume":"309","author":"L Rosenberg","year":"1983","unstructured":"Rosenberg L, Mitchell AA, Parsells JL, Pashayan H, Louik C, Shapiro S (1983) Lack of relation of oral clefts to diazepam use during pregnancy. N Engl J Med 309:1282\u20131285","journal-title":"N Engl J Med"},{"key":"13172_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.reprotox.2015.03.003","volume":"53","author":"AMS Alsaad","year":"2015","unstructured":"Alsaad AMS, Chaudhry SA, Koren G (2015) First trimester exposure to topiramate and the risk of oral clefts in the offspring: a systematic review and meta-analysis. Reprod Toxicol 53:45\u201350","journal-title":"Reprod Toxicol"},{"key":"13172_CR28","doi-asserted-by":"publisher","first-page":"e342","DOI":"10.1212\/WNL.0000000000004857","volume":"90","author":"S Hernandez-Diaz","year":"2018","unstructured":"Hernandez-Diaz S, Huybrechts KF, Desai RJ, Cohen JM, Mogun H, Pennell PB, Bateman BT, Patorno E (2018) Topiramate use early in pregnancy and the risk of oral clefts: a pregnancy cohort study. Neurology 90:e342\u2013e351","journal-title":"Neurology"},{"key":"13172_CR29","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.3390\/ijms18081721","volume":"18","author":"Y-H Lai","year":"2017","unstructured":"Lai Y-H, Ding Y-J, Moses D, Chen Y-H (2017) Teratogenic effects of topiramate in a zebrafish model. Int J Mol Sci 18:1721","journal-title":"Int J Mol Sci"},{"key":"13172_CR30","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1001\/jamaneurol.2023.0674","volume":"80","author":"JW Dreier","year":"2023","unstructured":"Dreier JW, Bj\u00f8rk M-H, Alvestad S et al (2023) Prenatal exposure to antiseizure medication and incidence of childhood- and adolescence-onset psychiatric disorders. JAMA Neurol 80:568\u2013577","journal-title":"JAMA Neurol"},{"key":"13172_CR31","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209175","volume":"102","author":"E Honybun","year":"2024","unstructured":"Honybun E, Cockle E, Malpas CB, O\u2019Brien TJ, Vajda FJ, Perucca P, Rayner G (2024) Neurodevelopmental and functional outcomes following in utero exposure to antiseizure medication: a systematic review. Neurology 102:e209175","journal-title":"Neurology"},{"key":"13172_CR32","doi-asserted-by":"publisher","first-page":"17362","DOI":"10.1038\/s41598-020-74409-x","volume":"10","author":"J Coste","year":"2020","unstructured":"Coste J, Blotiere P-O, Miranda S, Mikaeloff Y, Peyre H, Ramus F, Zureik M, Weill A, Dray-Spira R (2020) Risk of early neurodevelopmental disorders associated with in utero exposure to valproate and other antiepileptic drugs: a nationwide cohort study in France. Sci Rep 10:17362","journal-title":"Sci Rep"},{"key":"13172_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamaneurol.2023.4315","volume":"81","author":"MJ Cohen","year":"2024","unstructured":"Cohen MJ, Meador KJ, Loring DW et al (2024) Behavioral outcomes and neurodevelopmental disorders among children of women With epilepsy. JAMA Neurol 81:19\u201329","journal-title":"JAMA Neurol"},{"key":"13172_CR34","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000209448","volume":"102","author":"KJ Meador","year":"2024","unstructured":"Meador KJ, Cohen MJ, Loring DW et al (2024) Association of prenatal exposure to antiseizure medications with creative and executive function at age 4.5 years. Neurology 102:e209448","journal-title":"Neurology"},{"key":"13172_CR35","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1212\/WNL.0000000000003157","volume":"87","author":"RL Bromley","year":"2016","unstructured":"Bromley RL, Calderbank R, Cheyne CP et al (2016) Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate. Neurology 87:1943\u20131953","journal-title":"Neurology"},{"key":"13172_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000529141","volume":"92","author":"AYL Chan","year":"2023","unstructured":"Chan AYL, Gao L, Howard LM, Simonoff E, Coghill D, Ip P, Lau WCY, Taxis K, Wong ICK, Man KKC (2023) Maternal benzodiazepines and Z-drugs use during pregnancy and adverse birth and neurodevelopmental outcomes in offspring: a population-based cohort study. Psychother Psychosom 92:113\u2013123","journal-title":"Psychother Psychosom"},{"key":"13172_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/acps.13696","volume":"150","author":"C Andrade","year":"2024","unstructured":"Andrade C, Varadharajan N, Bascarane S, Menon V (2024) Gestational exposure to benzodiazepines or z-hypnotics and neurodevelopmental disorders in offspring: systematic review and meta-analysis. Acta Psychiatr Scand 150:65\u201377","journal-title":"Acta Psychiatr Scand"},{"key":"13172_CR38","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.1435","volume":"2","author":"A Lupattelli","year":"2019","unstructured":"Lupattelli A, Chambers CD, Bandoli G, Handal M, Skurtveit S, Nordeng H (2019) Association of maternal use of benzodiazepines and Z-hypnotics during pregnancy with motor and communication skills and attention-deficit\/hyperactivity disorder symptoms in preschoolers. JAMA Netw Open 2:e191435","journal-title":"JAMA Netw Open"},{"key":"13172_CR39","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210233","volume":"104","author":"A Berry-Noronha","year":"2025","unstructured":"Berry-Noronha A, Manoleehakul P, Rottler A, McGuiness G, Chen Z, Kuhn R, Vajda FJ, Perucca E, Antonic-Baker A, Perucca P (2025) Risk of adverse pregnancy outcomes associated with antiseizure medications and their indications: a systematic review and meta-analysis. Neurology 104:e210233","journal-title":"Neurology"},{"key":"13172_CR40","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/bcp.15752","volume":"90","author":"A Lavu","year":"2024","unstructured":"Lavu A, Vaccaro C, Zusman E et al (2024) Antiseizure medication use during pregnancy and neonatal growth outcomes: a systematic review and meta-analysis. Br J Clin Pharmacol 90:1827\u20131837","journal-title":"Br J Clin Pharmacol"},{"key":"13172_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.100849","volume":"38","author":"J Christensen","year":"2024","unstructured":"Christensen J, Zoega H, Leinonen MK et al (2024) Prenatal exposure to antiseizure medications and fetal growth: a population-based cohort study from the Nordic countries. Lancet Reg Health Eur 38:100849","journal-title":"Lancet Reg Health Eur"},{"key":"13172_CR42","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00415-013-7239-x","volume":"261","author":"G Veiby","year":"2014","unstructured":"Veiby G, Daltveit AK, Engelsen BA, Gilhus NE (2014) Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy. J Neurol 261:579\u2013588","journal-title":"J Neurol"},{"key":"13172_CR43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40263-017-0433-0","volume":"31","author":"G Pariente","year":"2017","unstructured":"Pariente G, Leibson T, Shulman T, Adams-Webber T, Barzilay E, Nulman I (2017) Pregnancy outcomes following in utero exposure to lamotrigine: a systematic review and meta-analysis. CNS Drugs 31:439\u2013450","journal-title":"CNS Drugs"},{"key":"13172_CR44","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40264-023-01307-2","volume":"46","author":"E Dudukina","year":"2023","unstructured":"Dudukina E, Sz\u00e9pligeti SK, Karlsson P et al (2023) Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries. Drug Saf 46:661\u2013675","journal-title":"Drug Saf"},{"key":"13172_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.seizure.2023.02.015","volume":"107","author":"M Hoeltzenbein","year":"2023","unstructured":"Hoeltzenbein M, Slimi S, Fietz A-K, Stegherr R, Onken M, Beyersmann J, Dathe K, Schaefer C (2023) Increasing use of newer antiseizure medication during pregnancy: an observational study with special focus on lacosamide. Seizure 107:107\u2013113","journal-title":"Seizure"},{"key":"13172_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1212\/WNL.0000000000001840","volume":"85","author":"T Tomson","year":"2015","unstructured":"Tomson T, Battino D, Bonizzoni E, Craig JJ, Lindhout D, Perucca E, Sabers A, Thomas SV, Vajda F, EURAP Study Group (2015) Antiepileptic drugs and intrauterine death: a prospective observational study from EURAP. Neurology 85:580\u2013588","journal-title":"Neurology"},{"key":"13172_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/ane.12816","volume":"137","author":"FJE Vajda","year":"2018","unstructured":"Vajda FJE, O\u2019Brien TJ, Graham J, Hitchcock AA, Lander CM, Eadie MJ (2018) Anti-epileptic drug exposure and risk of foetal death in utero. Acta Neurol Scand 137:20\u201323","journal-title":"Acta Neurol Scand"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13172-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13172-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13172-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T14:03:03Z","timestamp":1749909783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13172-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,28]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["13172"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13172-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,28]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all the authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Patient records in the FAERS database are anonymized and de-identified; therefore, ethical clearance and informed consent were not required for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"429"}}